Annovis Bio

ANVS34

$8.47arrow_drop_down1.96%-$0.17

ANVS34

$8.47

arrow_drop_down1.96%-$0.17

Performance History

Key Stats
Open	$8.59
Prev. Close	$8.64
EPS	-4.54
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$110.56M
PE Ratio	-

	LOW	HIGH
Day Range	8.45	8.82
52 Week Range	4.53	22.49

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-4.54

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Annovis Bio (ANVS)

Annovis Bio Inc (ANVS) is a biopharmaceutical company focused on developing novel therapeutics for the treatment of neurodegenerative diseases. The company's lead product candidate, ANVS401, is being developed for the treatment of Alzheimer's disease, Parkinson's disease, and other central nervous system disorders. ANVS401 has shown promising results in preclinical studies, with the potential to reduce toxic levels of misfolded proteins and restore normal neuronal function. The company is also developing ANVS301, a second product candidate targeting a different pathway involved in neurodegeneration.

ANVS stock has experienced significant volatility in the past year, with a 52-week range of $5.50 to $45.25. The current day range for ANVS is $20.75 to $23.50. Trading volume for ANVS has been relatively high, reflecting interest and investor activity in the company. The market capitalization of ANVS is approximately $500 million, indicating the perceived value of the company by investors.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Maria L. Maccecchini Ph.D.
Headquarters: Berwyn
Employees: 5
Exchange: NYSE

Keep an eye on Annovis Bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Annovis Bio 's (ANVS) price per share?

The current price per share for Annovis Bio (ANVS) is $8.47. The stock has seen a price change of -$0.17 recently, indicating a -1.97% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Annovis Bio (ANVS)?

For Annovis Bio (ANVS), the 52-week high is $22.49, which is 165.53% from the current price. The 52-week low is $4.53, the current price is 86.98% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Annovis Bio (ANVS) a growth stock?

Annovis Bio (ANVS) has shown an average price growth of 0.41% over the past three years. It has received a score of 32 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Annovis Bio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Annovis Bio (ANVS) stock price performance year to date (YTD)?

As of the latest data, Annovis Bio (ANVS) has a year-to-date price change of -55.26%. Over the past month, the stock has experienced a price change of -11.86%. Over the last three months, the change has been 42.59%. Over the past six months, the figure is -28.4%.

help

Is Annovis Bio (ANVS) a profitable company?

Annovis Bio (ANVS) has a net income of -$56.2M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$45.04M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Annovis Bio (ANVS)?

Annovis Bio (ANVS) has a market capitalization of $110.57M. The average daily trading volume is 165.04K, indicating the stock's liquidity and investor engagement.